VPHM... besides the fact that VPHM's vancocin is a very difficult drug to manufacture, the CEO also has been saying in recent conference calls that it would take likely take years for someone to get a new version of the drug approved by the FDA. Time and money is on the side of VPHM with this one.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.